Pro Medicus (PME.AX) Akcija Kursas

Pro Medicus Kursas

ASX·UŽDARTAS
175,73
​
Rinka uždaryta

Pajamos augo 17,3 % per metus per pastaruosius 19 metus iki 261,69 mln. AUD. Pelnas akcijai augo 20,8 % per metus per pastaruosius 19 metus. Pro Medicus grynoji marža dabar yra 101,4 %, išaugo nuo 47,6 % prieš kelerius metus. Pro Medicus šiuo metu siūlo apie 0,50 % dividendo pajamingumą. Išmokų koeficientas yra apie 73 % pelno. Dividendas augo 21,6 % per metus per pastaruosius 19 metus. Analitikų tikslinės kainos mediana yra 244,80 AUD, t. y. virš dabartinę kainą 39,3 %. Iš 17 analitikų 11 rekomenduoja pirkti — bendras konsensusas yra Pirkti.

Pro Medicus akcijos kaina

Gaukite šiuos duomenis per Eulerpool API

100 000 užklausų/mėn. nemokamai · be kortelės

Pro Medicus akcija ir akcijų analizė

„Pro Medicus Ltd.“ yra Australijos įmonė, specializuojasi medicininio vaizdavimo programinės įrangos sprendimų kūrimo ir platinimo srityje. Įmonė įkurta 1983 m., o jos būstinė yra Melburne.

Dažnai užduodami klausimai apie Pro Medicus akciją

The business model of Pro Medicus Ltd revolves around providing advanced healthcare imaging software solutions. The company specializes in developing and delivering a comprehensive range of radiology solutions that enhance workflow efficiency and improve patient care. Pro Medicus offers cutting-edge products like Visage AI, Visage 7, and Visage RIS, which allow healthcare professionals to efficiently manage and analyze medical images. By combining innovative technology with a customer-centric approach, Pro Medicus helps healthcare providers worldwide optimize their imaging operations and deliver accurate diagnoses. With its focus on developing state-of-the-art software solutions, Pro Medicus positions itself as a leader in the medical imaging industry.

Pro Medicus Ltd is primarily active in the healthcare industry.

The main competitors of Pro Medicus Ltd in the market include other medical imaging companies such as Carestream Health, Change Healthcare, and Sectra AB. These companies also specialize in providing medical imaging solutions and technology to healthcare providers and are prominent players in the industry. Pro Medicus Ltd competes with them in terms of product offerings, innovation, customer base, and market share.

Pro Medicus Ltd is a renowned healthcare imaging and information technology provider. Established in 1983, the company has a rich history of pioneering innovative solutions in the medical imaging industry. With a strong focus on radiology, Pro Medicus has developed advanced imaging software that improves efficiency and enhances patient care. The company's success is attributed to its commitment to research and development, resulting in cutting-edge technologies and multiple industry awards. Pro Medicus operates globally, serving prominent healthcare institutions and professionals. With its profound expertise and dedication to advancing medical imaging technology, Pro Medicus Ltd continues to lead the industry in providing innovative solutions for the healthcare sector.

Some significant milestones achieved by Pro Medicus Ltd include the successful expansion into major global markets, such as the United States and Europe, further solidifying its position as a leading provider of healthcare imaging solutions. The company has also experienced continuous revenue growth, achieving record-breaking financial results year after year. Pro Medicus Ltd has consistently developed and released innovative software solutions, enhancing efficiency and productivity for healthcare professionals. Additionally, the company has formed strategic partnerships with top-tier healthcare organizations, further establishing its reputation as a trusted industry leader. These accomplishments have propelled Pro Medicus Ltd's growth and success in the competitive healthcare technology sector.

Pro Medicus Ltd primarily operates in Australia and the United States.

Pro Medicus Ltd is a leading healthcare IT solutions provider with a strong commitment to excellence and innovation. The company's core values revolve around delivering exceptional products and services that empower healthcare professionals to enhance patient care and outcomes. Pro Medicus emphasizes a customer-centric approach and strives to provide customized solutions tailored to meet the unique needs of its clients. With a clear focus on technological advancements and high-quality imaging software, Pro Medicus constantly pushes the boundaries in the healthcare industry. By fostering a culture of collaboration and continuous improvement, Pro Medicus Ltd is dedicated to transforming the way medical images are managed and shared worldwide.

Analitikai šiuo metu nustato vidutinę Pro Medicus akcijos tikslinę kainą 226,59 AUD (mediana: 244,80 AUD), t. y. +28,9 % palyginti su paskutine kaina. Konsensusas pagrįstas 17 analitikų reitingais.

17 analitikai šiuo metu vertina Pro Medicus akciją: 13 rekomenduoja pirkti, 4 laikyti ir 0 parduoti.

Pagal dabartinį kursą Pro Medicus akcija kainuoja 108,60 EUR (175,73 AUD).

Pro Medicus akcija (PME.AX) kotiruojama 3 biržose, įskaitant: ASX (PME.AX), Frankfurt (PMC.F).

Pro Medicus Ltd is a global company specializing in providing advanced IT solutions for the healthcare industry. They offer innovative information and image management solutions that are used by leading healthcare organizations worldwide. Their main divisions include Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and Telemedicine. Their PACS solutions allow hospitals and healthcare organizations to store, manage, and share digital images from medical diagnostic devices such as CT, MRI, and X-ray machines. These solutions are scalable and provide high-quality image quality for radiologists and other specialists to make informed diagnoses. Their RIS is an integrated solution designed specifically for radiology departments and practices, providing complete patient and order management, as well as integrated workflow tools to improve the efficiency and accuracy of diagnosing and evaluating medical imaging data. Their telemedicine solutions enable radiology professionals to edit and share medical images remotely over the internet, particularly beneficial in facilities with limited resources or for quick access to medical images in emergency diagnoses. In addition, Pro Medicus Ltd also offers specialized solutions for clinical decision support, automated medical image analysis, and patient management. Their clinical decision support provides assistance to medical professionals in diagnosis and treatment monitoring, while the automated analysis of medical image data allows for the quick processing of large amounts of data, producing results that can be utilized by professionals for diagnostic purposes. Their patient management solutions provide comprehensive capture and management of health data that can be used by doctors and other professionals to develop better treatment options for their patients. Pro Medicus Ltd is a global company with a strong focus on research and development. They have partnerships with leading healthcare organizations worldwide and possess a strong portfolio of intellectual property. Their business model is based on the sale of products and services specifically designed for the needs of the healthcare industry. The company emphasizes innovation, customer satisfaction, and delivering high-quality solutions that are scalable and flexible for various users. Overall, Pro Medicus Ltd is an innovative market leader in the field of medical IT solutions. They are globally recognized for their products and services and are expected to continue playing a significant role in the healthcare industry.

pelnas Pro Medicus yra 261,69 mln. AUD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.

grynasis pelnas Pro Medicus yra 265,34 mln. AUD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.

Kainų ir nuomos santykis (KGV) Pro Medicus šiuo metu yra 69,30. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Pro Medicus akcijos vertę.

Kainų ir pardavimų santykis (KUV) Pro Medicus šiuo metu yra 70,27. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Pro Medicus akcijos įvertinimo metrika.

Eulerpool kokybės balas Pro Medicus yra 8/10.

Pro Medicus ISIN yra AU000000PME8. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.

Pro Medicus WKN yra 591723. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.

Pro Medicus prekybos žymė yra PME.AX. Ši biržos žymė naudojama Pro Medicus akcijoms prekiauti biržoje.

Tikroji vertėTerminal
144,10 AUD
Per/Nepakankamai vertintaTerminal
Teisingai vertinta
Sektorius
Industrija
Sveikatos priežiūros technologija
Akcijų skaičius
Darbuotojai
Pajamos vienam darbuotojui
3,31 mln. AUD
Pajamų augimas Ø5 metai
EBIT augimas Ø5 metai
Grynojo pelno augimas Ø5 metai
Svetainė promed.com.au
Šalis
Australija
Valiuta
AUD
Pirminis viešas pasiūlymas
2000-10-10
ISIN
AU000000PME8
CUSIP
Q77301101
SEDOL
6292782
Rinkos kapitalizacija
52 savaičių diapazonas
AAQS
9 / 10
PEG
10,24
P/E santykis
K/P santykise 2027
96,75
K/P santykise 2028
76,75
K/P santykise 2029
62,37
K/P santykise 2030
45,44
K/P santykise 2031
69,74
K/A santykise
54,32
EV/EBIT
93,78
P/B santykis
40,79
ROE (nuosavo kapitalo grąža)
ROA (turto grąža)
ROCE (grąža iš panaudoto kapitalo)
ROIC (grąža iš investuoto kapitalo)
58,85 %
Dividendas
Dividendų grąža
0,50 %
Numatyta dividendų grąža
0,42 %
Išmokų koeficientas
72,54 %
Dividendų augimas Ø5M
23,03 %
Dividendai per metus
2
Dividendai išmokami nuo
14 metų
Dividendai nesmažinti nuo
10 metų
Dividendai padidinti nuo
10 metų
Sumažinimo mokestis
30,00 %
Paskutinį kartą atnaujinta 2026-10-18 07:34

Pro Medicus Biržos simbolis

ASX · PME.AXFRANKFURTAS · PMC.FOTC · PMCUF

Pro Medicus FIGI

PME:AU · BBG000C41MZ9PME:AT · BBG000C41NB3PMCUF:US · BBG000H06487PMCUF:UV · BBG000H07L06PME:AH · BBG002F3J5Y3PMC:GR · BBG00GCTJN24PMC:GF · BBG00GCTJN33PMEEUR:EO · BBG00GD4N8Z0PMEEUR:XH · BBG00GD4N924PMEEUR:XF · BBG00GD4N942PMEEUR:XE · BBG00GD4N960PMEEUR:XJ · BBG00GD4N979

Visos Pro Medicus pagrindinės charakteristikos ir giluminė analizė

Mūsų akcijų analizė Pro Medicus akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Pro Medicus. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: